Topical antibiotic composition for the prevention of lyme disease
AssigneeIxodes AG
InventorsGustave HUBER, Huttenes UTA, Caroline ROOSENS-VON BIDDER
Life of this patent
Estimating the term…
Abstract
The invention relates to topical pharmaceutical compositions and methods related to Borrelia burgdorferi toxins, in particular, the present invention provides compositions and methods for the treatment of infections caused by Borrelia burgdorferi and in particular for the prevention of Lyme disease.
Claims9
1-12. (canceled)
A process for the preparation of a topical pharmaceutical composition for the prevention of Lyme disease comprising combining azithromycin, a solvent with greater volatility than water, a solvent less volatile than water, and a solidifying agent.
A process for the preparation of a topical pharmaceutical composition for the elimination of Borrelia burgdorferi resulting from a tick bite comprising combining azithromycin, a solvent with greater volatility than water, a solvent less volatile than water, and a solidifying agent.
A topical pharmaceutical composition for the prevention of Lyme disease or for the elimination of spirochetal, cystic and/or spherical forms of Borrelia burgdorferi resulting from a tick bite, comprising azithromycin, a solvent with greater volatility than water, a solvent less volatile than water, and a solidifying agent.
Dependencies are inferred from the claim text.